A Fatal Antenatal Diagnosis: Case Report of Anencephaly

Authors

  • Aparna Sarwade
  • Radhika Dhedia

Keywords:

Acrania,Karyoytyping, Folic acid supplementation

Abstract

Anencephaly is a fatal neural tube defect characterized by the absence of the calvarium and major portions of the brain, resulting from failed closure of the cranial end of the neural tube during early embryogenesis. Despite declining prevalence rates in recent decades due to folic acid supplementation and food fortification programs, it remains a significant cause of perinatal mortality. We report a case of anencephaly diagnosed in a 21-year-old primigravida at 20 weeks of gestation. The pregnancy was the result of a second-degree consanguineous union, with no significant personal or familial history of congenital anomalies. Ultrasonographic evaluation revealed absence of the calvarial vault, disorganized brain tissue, and spinal anomalies, consistent with acrania–exencephaly sequence and cervical spina bifida. After appropriate counselling and informed consent, medical termination of pregnancy was carried out using mifepristone and misoprostol. Post-delivery, the foetal specimen was sent for karyotyping, which revealed a normal chromosomal profile. This case underscores the importance of early prenatal screening, particularly in populations with genetic risk factors. Anencephaly, being incompatible with life, necessitates timely diagnosis and sensitive, multidisciplinary counselling to aid parental decision-making. Public health measures, especially periconceptional folic acid supplementation, have proven highly effective in reducing the incidence of neural tube defects. Preventive strategies, including folic acid supplementation and genetic counselling, are vital in reducing the burden of anencephaly. Early detection through routine antenatal care allows for informed clinical decisions and better psychological support for affected families

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong L-Y C. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001;285:2981--6.

Kancherla, V., Wagh, K., Priyadarshini, P., Pachón, H., & Oakley, G. P. Jr. (2022). A global update on the status of prevention of folic acid-preventable spina bifida and anencephaly in year 2020: 30-Year anniversary of gaining knowledge about folic acid's prevention potential for neural tube defects. Birth Defects Research, 114(20), 1392–1403

Hopkins Tanne J. US study shows that folic acid fortification decreases neural tube defects. BMJ. 2005 Sep 17;331(7517):594. PMCID: PMC1215584.

De Wals, P., Tairou, F., Van Allen, M. I., Uh, S. H., Lowry, R. B., Sibbald, B., Evans, J. A., Van den Hof, M. C., Zimmer, P., Crowley, M., Fernandez, B., Lee, N. S., & Niyonsenga, T. (2007). Reduction in neural-tube defects after folic acid fortification in Canada. The New England journal of medicine, 357(2), 135–142. https://doi.org/10.1056/NEJMoa067103

Shlobin, N. A., LoPresti, M. A., Du, R. Y., & Lam, S. (2021). Folate fortification and supplementation in prevention of folate-sensitive neural tube defects: a systematic review of policy. Journal of Neurosurgery: Pediatrics, 27(3), 294-310. https://doi.org/10.3171/2020.7.PEDS20442

Chaplin, J., Schweitzer, R., & Perkoulidis, S. (2005). Experiences of prenatal diagnosis of spina bifida or hydrocephalus in parents who decide to continue with their pregnancy. Journal of Genetic Counseling, 14(2), 151-162.

Parens, E., & Asch, A. (2003). Disability rights critique of prenatal genetic testing: reflections and recommendations. Mental retardation and developmental disabilities research reviews, 9(1), 40-47

Downloads

Published

2025-05-07

How to Cite

1.
Sarwade A, Dhedia R. A Fatal Antenatal Diagnosis: Case Report of Anencephaly. J Neonatal Surg [Internet]. 2025May7 [cited 2025Sep.24];14(21S):429-31. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/5311